Biotech Lands $8.5 Million to Develop Tumor Tracker

A Seattle company developing an implant to track and treat cancerous tumors has landed $8.5 million in venture capital, part of a round of fund raising the company hopes will reach $34.9 million. Calypso Medical Technologies Inc. reported raising the funds as part of a Series C preferred stock financing, according to documents filed with the state Department of Financial Institutions.

Puget Sound Business Journal (http://www.bizjournals.com/seattle/stories/2005/02/28/story5.html)